India's Pharma Sector: Goyal Meets Stakeholders Amid Global Tariff Concerns
TL;DR
Indian Commerce Minister Piyush Goyal met with pharma stakeholders to discuss growth, regulatory reforms, and innovation amid global tariff concerns. The government aims to build a future-ready sector with affordable healthcare, and Indian exports are expected to remain resilient.
Tags
Indian Commerce and Industry Minister Piyush Goyal met with pharmaceutical stakeholders to discuss growth and regulation amid global tariff concerns. The meeting focused on strengthening industry growth and regulatory reforms, including innovation, data protection frameworks, and investment commitments. Goyal reiterated the government's commitment to developing a future-ready, innovation-led pharma sector and delivering affordable healthcare solutions. The global pharmaceutical industry is assessing the potential implications of proposed US tariff measures, but industry representatives in India have expressed confidence that Indian pharmaceutical exports will not be significantly affected.
